The NUBIN is the NeuroUnit Biomarkers for Inflammation and Neurodegeneration.
NUBIN is a collaboration between several departments of the VUmc for a common goal: the development of assays in body fluids useful for diagnosis and monitoring of neuroinflammatory and neurodegenerative diseases such as AD and MS.
The diagnosis and monitoring of chronic neuroinflammatory and neurodegenerative diseases, such as Multiple Sclerosis (MS) and Alzheimer’s Disease (AD), is severely hampered by the inaccessibility of the affected brain for these purposes. There is a lack of biochemical markers that can be measured in body fluids such as cerebrospinal fluid (CSF) or blood, which could provide information about these diseases. Such biomarkers would increase the possibilities to understand the pathobiochemical mechanisms, to obtain information about the prognosis, to develop therapies and to monitor the effects of therapeutic interventions.
The strength of the NUBIN lies in the collaboration of research groups with a common interest in neuroinflammation and neurodegeneration. In particular the NUBIN profits from:
NUBIN's daily coordination is performed by Dr. Charlotte Teunissen
A steering group has monthly meetings to define strategies and determine the activities of NUBIN.
| Molecular Cell Biology: |
C.E. Teunissen PhD (coordinator) C.D. Dijkstra MD PhD |
| Neurology MS: |
J. Killestein PhD L. van der Voort MD |
| Neurology AD: |
Ph. Scheltens MD PhD F. Bouwman MD |
| Clinical Chemistry: |
M.A. Blankenstein PhD (chair) C. Mulder MSc A. Kok Bsc |
| Medical Genomics: |
P. Heutink PhD P. Rizzu PhD |
| Pathology: |
A. Rozemuller R. Veerhuis (AD) PhD |
Members of the steering group are representatives of groups that substantially contribute to biobanking and share their biological samples.